Pistachio green brain discolouration associated with methylene blue use: An autopsy series

Pathology

Volumn 42, Issue 7, 2010, Pages 681-683

  Prayson, Richard A ^a   Douglas, Elizabeth A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649235232     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313025.2010.523685     Document Type: Letter

References (19)

1. Baraka AS, Ayouh CM, Yazbeck-Karam V, et al. Prophylactic methylene blue in a patients with congenital methemoglobinemia. Can J Anesth 2005;52:258-61.
2. Cvetkovic BR, Cvetkovic VR, Rosic ZV, Milenkovic D. Late methylene blue appearance in urine after local treatment of cutaneous fistula in hip osteomyelitis as a first sign of renal failure. Acta Chir Iugosl 2008;55:117-20.
3. Martin-Granizo R, Perez-Herrero MC, Sanchez-Cuellar A. Methylene blue staining and probing for fistula resection: application in a case of bilateral congenital preauricular fistulas. Intl J Oral Maxillofacial Surg 2002;31:439-41.
4. Meekin GK. Intraoperative use of methylene blue to localize parathyroid adenoma. Laryngoscope 1998;108:772-3.
5. Argenziano M, Chen M, Choudri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovascular Surg 1998;116:973-80.
6. Cremer J, Martin M, Redel H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thoracic Surg 1996;61:1714-20.
7. Evora PR, Ribierto PJ, De Andrade JC. Methylene blue administration in SIRS after cardiac operations. Ann Thorac Surg 1997;63:1212-3.
8. Leyh RG, Kofidis T, Struber M, et al. Methylene blue: the drug of choice for catecholamine-refractory vasopelegia after cardiopulmonary surgery. J Thorac Cardiovasc Surg 2003;125:1426-31.
9. Mayer B, Brunner F, Schnidt K. Novel actions of methylene blue. Eur Heart J 1994;14(Suppl): 22-6.
10. Preiser JC, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: a clinical trial. Critical Care Med 1995;25:2589-664.
11. Shanmugam G. Vasopelegic syndrome - the role of methylene blue. Eur J Cardiothorac Surg 2005;28:705-710.
12. Yiu P, Robin J, Pattison CW. Reversal of refractory hypotension with single dose methylene blue after coronary artery bypass surgery. J Thorac Cardiovasc Surg 1999;118:195-6.
13. Yap KP, Chng HC. Urinary discoloration after rectal instillation of methylene blue dye. Singapore Med J 2003;44:268.
14. Clifton J, Leikin JB. Methylene blue. Am J Ther 2003;10:289-91.
15. Palmer R M J. The discovery of nitric acid in the vessel wall. A unifying concept in the pathogenesis of sepsis. Arch Surg 1993;128:396-401.
16. Pollack G, Pollack A, Delfiner J, Fernandez J. Parathyroid surgery and methylene blue: A review with guidelines for safe intraoperative use. Laryngoscope 2009;119:1941-6.
17. Poppers PJ, Mastri AR, Lebeaux M, Covino BG. The effect of methylene blue on neural tissue. Anesthesiology 1970;33:335-40.
18. Reyes-Mugica M, Chou P, Byrd S, et al. Nevomelanocytic proliferations in the central nervous system of children. Cancer 1993;72:2277-85.
19. Liu W, Prayson RA. Dura mater involvement in ochronosis (alkaptonuria). Arch Pathol Lab Med 2001;125:961-3.